These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16022165)

  • 1. Adaptive regression.
    Proschan MA; Leifer E; Liu Q
    J Biopharm Stat; 2005; 15(4):593-603. PubMed ID: 16022165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive covariate adjustment in clinical trials.
    Wang SJ; Hung HM
    J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial.
    Weir CJ; Lees KR
    Stat Med; 2003 Mar; 22(5):705-26. PubMed ID: 12587101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].
    Byar D; Chastang C
    Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal multivariate matching before randomization.
    Greevy R; Lu B; Silber JH; Rosenbaum P
    Biostatistics; 2004 Apr; 5(2):263-75. PubMed ID: 15054030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical comparison of random allocation methods in cancer clinical trials.
    Hagino A; Hamada C; Yoshimura I; Ohashi Y; Sakamoto J; Nakazato H
    Control Clin Trials; 2004 Dec; 25(6):572-84. PubMed ID: 15588744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current issues with covariate adjustment in the analysis of data from randomized controlled trials.
    Alemayehu D
    Am J Ther; 2011; 18(2):153-7. PubMed ID: 19797942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
    Hou Y; Ding V; Li K; Zhou XH
    J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New algorithm for treatment allocation reduced selection bias and loss of power in small trials.
    Hofmeijer J; Anema PC; van der Tweel I
    J Clin Epidemiol; 2008 Feb; 61(2):119-24. PubMed ID: 18177784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical consideration of adaptive methods in clinical development.
    Chow SC; Chang M; Pong A
    J Biopharm Stat; 2005; 15(4):575-91. PubMed ID: 16022164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covariate-adjusted response-adaptive designs for binary response.
    Rosenberger WF; Vidyashankar AN; Agarwal DK
    J Biopharm Stat; 2001 Nov; 11(4):227-36. PubMed ID: 12018777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization.
    Ciolino J; Zhao W; Martin R; Palesch Y
    Contemp Clin Trials; 2011 Mar; 32(2):250-9. PubMed ID: 21078415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of minimization in clinical trials.
    Taves DR
    Contemp Clin Trials; 2010 Mar; 31(2):180-4. PubMed ID: 20060500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Randomization for controlled therapeutic trials].
    Schemper M
    Wien Klin Wochenschr; 1982 Nov; 94(22):604-9. PubMed ID: 7164464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment by drawing lots in a therapeutic trial with a balance distribution of prognostic factors: the minimization method].
    Mollié A; Hill C
    Rev Epidemiol Sante Publique; 1988; 36(2):138-43. PubMed ID: 3045921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.